Brief: Prostatype Genomics Announces Strong Results For Prostatype In First Step Validation Study Of Asian Population
March 31 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* PROSTATYPE GENOMICS ANNOUNCES STRONG RESULTS FOR
PROSTATYPE® IN
FIRST STEP VALIDATION STUDY OF ASIAN POPULATION
* RESULTS IN LINE WITH WHAT WE HAVE SEEN IN EXTERNAL
VALIDATION
STUDIES PERFORMED IN EUROPE, MEANING THAT APPROXIMATELY 1/3 OF
PATIENTS ARE RECLASSIFIED BY USING PROSTATYPE® TECHNOLOGY
Source text for Eikon: ID:nWkr1797Dk
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587696600;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Brief: Prostatype Genomics Enters SEK 6.0 Mln Agreement With Vator Securities For To6
Brief: Prostatype Genomics AB H1 2026 Net Sales SEK 457,000
Brief: Prostatype Genomics Resolves On Directed Issue
Brief: Prostatype Genomics To Receive About SEK 47.4 Mln From Rights Issue